Without disclosing specifics, one source who spoke with peHUB.com said that Monitor Clipper typically puts $50 million to $100 million in equity into transactions. The purchase price was not disclosed. ScriptSave has no institutional investors, a source confirmed.
The prescription benefit management space has been heating up as a greater percentage of Americans (namely, Baby Boomers) have an increased dependence on medication. EBITDA multiples were not disclosed, either, but the PBM space continues to see M&A activity and interest from financial sponsors.
It won’t be Monitor Clipper’s first trip to the healthcare space, either. According to the firm’s Web site, current portfolio investments include CMC Biologics; Access Communications, a provider of marketing and advertising services to healthcare clients; and Medical Services Company, a provider of healthcare products and services to U.S. workers’ compensation claimants.
Monitor Clipper and ScriptSave did not respond with comments for this piece.